Approval based on results from three pivotal trials showing treatment with ZULRESSO provided significant and rapid reduction of depressive symptoms within days
Postpartum depression is the most common medical complication of childbirth, estimated to affect approximately 400,000 women annually …
BOSTON – (BUSINESS WIRE) – March 6, 2019 – Today, the health care organization founded by Amazon (NASDAQ: AMZN), Berkshire Hathaway (NYSE: BRK.A, BRK.B), and JPMorgan Chase (NYSE: JPM), announced its name – Haven – and launched a new …
A person’s character is revealed during times of great pressure and distress. A great way to test out someone’s character is to observe how they react when things don’t go according to plan.
What if there were a way for …
Vor Biopharma, an immuno-oncology company pioneering engineered hematopoietic stem cell (HSC) therapies for the treatment of hematological malignancies, today announced a $42 million Series A financing round led by 5AM Ventures and RA Capital Management. Johnson & Johnson Innovation – …
Waltham, Mass.-based Morphic Therapeutic and Janssen Biotech, a division of Johnson & Johnson, entered into a collaborative deal to develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies.
The collaboration between the companies focuses on …
